Healius Limited (ASX:HLS)
0.9500
0.00 (0.00%)
At close: Dec 19, 2025
Healius Market Cap
Healius has a market cap or net worth of 689.83 million as of December 19, 2025. Its market cap has decreased by -34.26% in one year.
Market Cap
689.83M
Enterprise Value
1.54B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.95
Market Cap Chart
Since August 29, 2000, Healius's market cap has increased from 478.57M to 689.83M, an increase of 44.14%. That is a compound annual growth rate of 1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 689.83M | -30.66% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | 2.32B | 35.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.46B |
| Pro Medicus | 22.71B |
| Cochlear | 16.85B |
| Sonic Healthcare | 11.16B |
| Ramsay Health Care | 7.96B |
| Ansell | 5.06B |
| Telix Pharmaceuticals | 4.01B |
| Mesoblast | 3.73B |